user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 432624 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

Momenta Pharmaceuticals Shares Sinking Lower, Down 1.4%

Published on Wed, 01/30/2013 - 13:24
By Adrienne Chilton

Momenta Pharmaceuticals (NASDAQ:MNTA) is one of today's biggest movers, down 1.4% to $12.87. The Dow Jones Industrial Average is now trading fractionally higher to 13,956 and the S&P is trading fractionally lower to 1,507.

Over the past year, Momenta Pharmaceuticals has traded in a range of $10.05 to $21.00 and is now at $12.87, 28% above that low. The 200-day and 50-day moving averages have moved 0.24% lower and 0.90% higher over the past week, respectively.

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Momenta Pharmaceuticals (NASDAQ:MNTA) has potential upside of 10.7% based on a current price of $12.87 and analysts' consensus price target of $14.25. The stock should hit resistance at its 200-day moving average (MA) of $13.57, as well as support at its 50-day MA of $11.59.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

TD Securities Made the Right Call, Pan A...

Pan American Silver was downgraded from Buy to Hold by TD Securities one week ago. The ...

Analyst Rating In Review: Medivation Bid...

One week ago Medivation (NASDAQ:MDVN) was downgraded from Buy to Neutral at Goldman Sac ...

Auxilium Pharmaceuticals In Retrospect: ...

RBC Capital downgraded Auxilium Pharmaceuticals (NASDAQ:AUXL) from Outperform to Sector ...

Analyst Rating In Review: Marvell Techno...

A week ago, JMP Securities upgraded Marvell Technology from Underperform to Market Perf ...

Buffalo Wild Wings Fulfills the Promise:...

A week ago, Miller Tabak upgraded Buffalo Wild Wings from Hold to Buy. Buffalo Wild Wi ...

Ericsson Down 1.6% Since UBS Downgraded ...

UBS downgraded Ericsson (NASDAQ:ERIC) from Buy to Neutral a week ago. The shares close ...

Analyst Rating Flashback: SYNNEX Up 8.1%...

Raymond James upgraded SYNNEX (NYSE:SNX) from Market Perform to Outperform a week ago. ...

Freeport-McMoRan In Retrospect: Shares D...

A week ago, Tigress Financial downgraded Freeport-McMoRan from Strong Buy to Neutral. ...